MONTREAL, QUEBEC–(Marketwire – 02/03/11) – A5 Laboratories Inc. (A5 Labs) (OTC.BB:AFLB – News) announced today the office of Biohazard and Containment Safety
MONTREAL, QUEBEC–(Marketwire – 02/01/11) – A5 Laboratories Inc. (A5 Labs) (OTC.BB:AFLB – News) announced today the successful production of its VI-1718 interferon product by its European manufacturing partner.
A5 Laboratories provides contract analytical, regulatory and product development services to the Pharmaceutical industry. With a dedicated commitment to its client’s needs, A5 Laboratories offers a full range of services to the pharmaceutical industry in variety of fields, all in compliance with Good Laboratory Practices and current Good Manufacturing Practices regulations.